Quick Answer
INVO Fertility, Inc. reported R&D Expense of $489.7 thousand for fiscal year 2024.
INVO Fertility, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $489.7K | +195.1% |
| 2023 | $165.9K | -69.5% |
| 2022 | $544.0K | +151.4% |
| 2021 | $216.4K | -45.7% |
| 2020 | $398.4K | — |
| 2019 | $0.00 | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | $265.7K | +5343.9% | +5343.9% |
| March 31, 2024 | $4.9K | -93.4% | +82.9% |
| September 30, 2023 | $2.7K | -98.5% | -96.8% |
| June 30, 2023 | $83.8K | -56.0% | +14.1% |
| March 31, 2023 | $73.5K | -29.4% | -58.1% |
| September 30, 2022 | $175.3K | +216.4% | -8.1% |
| June 30, 2022 | $190.8K | +515.0% | +83.1% |
| March 31, 2022 | $104.2K | +57.2% | +88.1% |
- INVO Fertility, Inc. showed an increase of +195.1% in R&D Expense compared to the prior fiscal year.
- The most recent figure is from INVO Fertility, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: